120 related articles for article (PubMed ID: 7987857)
1. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.
Kaipainen A; Vlaykova T; Hatva E; Böhling T; Jekunen A; Pyrhönen S; Alitalo K
Cancer Res; 1994 Dec; 54(24):6571-7. PubMed ID: 7987857
[TBL] [Abstract][Full Text] [Related]
2. Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia-reperfusion.
Lin TN; Nian GM; Chen SF; Cheung WM; Chang C; Lin WC; Hsu CY
J Cereb Blood Flow Metab; 2001 Jun; 21(6):690-701. PubMed ID: 11488538
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
[TBL] [Abstract][Full Text] [Related]
4. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF
Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650
[TBL] [Abstract][Full Text] [Related]
6. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis.
Korhonen J; Polvi A; Partanen J; Alitalo K
Oncogene; 1994 Feb; 9(2):395-403. PubMed ID: 7507228
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation.
Becker D; Lee PL; Rodeck U; Herlyn M
Oncogene; 1992 Nov; 7(11):2303-13. PubMed ID: 1437152
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas.
Kobrin MS; Yamanaka Y; Friess H; Lopez ME; Korc M
Cancer Res; 1993 Oct; 53(20):4741-4. PubMed ID: 8402651
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.
Nürnberg W; Tobias D; Otto F; Henz BM; Schadendorf D
J Pathol; 1999 Dec; 189(4):546-51. PubMed ID: 10629556
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
11. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development.
Dumont DJ; Fong GH; Puri MC; Gradwohl G; Alitalo K; Breitman ML
Dev Dyn; 1995 May; 203(1):80-92. PubMed ID: 7647376
[TBL] [Abstract][Full Text] [Related]
12. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of vascular endothelial growth factor, relative receptors and ligands in vascular endothelial cells of cerebral arteriovenous malformation].
Li J; Gao Y; Zhao M
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):675-8. PubMed ID: 11769600
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of fibroblast growth factor receptor 1 expression in human glioblastoma cell contributes to the cell growth suppression].
Yamada SM; Yamaguchi F; Morrison RS; Takahashi H; Teramoto A
No To Shinkei; 1998 Dec; 50(12):1101-5. PubMed ID: 9989355
[TBL] [Abstract][Full Text] [Related]
15. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.
Gutman M; Singh RK; Radinsky R; Bar-Eli M
Anticancer Res; 1994; 14(5A):1759-65. PubMed ID: 7847808
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
18. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
[TBL] [Abstract][Full Text] [Related]
19. Expression of the fibroblast growth factor receptor-1 in human normal tissues and tumors determined by a new monoclonal antibody.
Morikawa Y; Ishihara Y; Tohya K; Kakudo K; Seo MK; Matsuura N
Arch Pathol Lab Med; 1996 May; 120(5):490-6. PubMed ID: 8639054
[TBL] [Abstract][Full Text] [Related]
20. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma.
Ueki T; Koji T; Tamiya S; Nakane PK; Tsuneyoshi M
J Pathol; 1995 Dec; 177(4):353-61. PubMed ID: 8568589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
